Medication Trial for Cervical Osmotic Dilators Placement
Study Description
“Cervical Preparation With Mifepristone Prior to Osmotic Dilators”
The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D&E) procedures.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - Mifepristone 200 MG
Ingestion of study medication vs placebo
Drug - Placebo Oral Tablet
Ingestion of study medication vs placebo
Additional Information
Official Study Title
Cervical Preparation With Mifepristone Prior to Osmotic Dilators: A Randomized, Double-blind, Placebo-controlled Pilot Study
Clinical Trial ID
NCT03714880
ParticipAid ID
av2jma
